USTR Considers Removal of 301 Duties on COVID-19-Related Medical Care Products

Published date25 March 2020
AuthorJennifer McCadney
Subject MatterCorporate & Commercial,International
Law FirmKelley Drye & Warren LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT